Tesamorelin

Tesamorelin is a synthetic 44-amino-acid analog of human growth-hormone-releasing hormone (GHRH). Supplied as a lyophilized powder, it is intended for in-vitro laboratory research into GHRH-receptor signaling and the growth-hormone axis.

Molecular Profile

• CAS Number218949-48-5
• Molecular Weight5,135.9 g/mol
• Molecular FormulaC₂₂₁H₃₆₆N₇₂O₆₇S
• SequenceGHRH(1-44) analog, 44 aa
• Purity≥99.7% (HPLC-MS/MS)
• FormatLyophilized white powder
• Storage−20°C, desiccated
• ReconstitutionSterile bacteriostatic water

Research Context

Tesamorelin is studied in the preclinical literature as a stabilized GHRH analog used to investigate somatotroph signaling and GH / IGF-1 axis biology in laboratory models.

Quality Assurance

Every lot is independently tested for identity and purity by SideChain Analytics (HPLC-MS/MS), and a Certificate of Analysis is available for each batch. Produced and shipped from within Canada.

Available exclusively for in-vitro laboratory research. Not a drug, natural health product, or food; not for human or veterinary use, and not evaluated for diagnostic or therapeutic application. Researchers are responsible for compliance with all applicable regulations.

• CompoundTesamorelin
• Strength10 mg per vial
• Pack sizes1 vial · 3 pack · 6 pack
• AppearanceLyophilized white powder
• Storage−20°C, protect from light
• VerificationThird-party HPLC-MS/MS (SideChain Analytics)
• OriginNorth American made · ships from Canada

Reported in preclinical, in-vitro literature in the following research areas:

• GHRH-receptor signaling
• GH / IGF-1 axis research
• Somatotroph models
• Metabolic-pathway research

These are areas of laboratory investigation only. No physiological, clinical, or health outcome is claimed or implied for any use of this compound.

As a GHRH(1-44) analog, tesamorelin has been reported to bind the GHRH receptor and stimulate growth-hormone-releasing signaling in preclinical models.